These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 4691800

  • 1. [Use of enzymatic uricolysis in the treatment of hyperuricemia of renal origin].
    Brogard JM, Frankhauser J, Stahl A.
    Schweiz Med Wochenschr; 1973 Mar 17; 103(11):404-10. PubMed ID: 4691800
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Clinical experience with a new uricolytic agent].
    Alessandri C, Violi F, Bonavita MS.
    Recenti Prog Med; 1986 Mar 17; 77(3):147-8. PubMed ID: 3715181
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Physiopathology and treatment of hyperuricemia and gout].
    Louyot P, Pourel J, Gaucher A, Montet Y.
    Rein Foie; 1971 Mar 17; 13():103-27. PubMed ID: 5147550
    [No Abstract] [Full Text] [Related]

  • 9. [Rasburicase (Fasturtec)].
    Vogt B, Gugger M, Frey FJ.
    Ther Umsch; 2004 Sep 17; 61(9):579-82. PubMed ID: 15493120
    [Abstract] [Full Text] [Related]

  • 10. Population pharmacokinetic and pharmacodynamic analysis of pegloticase in subjects with hyperuricemia and treatment-failure gout.
    Yue CS, Huang W, Alton M, Maroli AN, Waltrip RW, Wright D, Marco MD.
    J Clin Pharmacol; 2008 Jun 17; 48(6):708-18. PubMed ID: 18420531
    [Abstract] [Full Text] [Related]

  • 11. PEG-uricase in the management of treatment-resistant gout and hyperuricemia.
    Sherman MR, Saifer MG, Perez-Ruiz F.
    Adv Drug Deliv Rev; 2008 Jan 03; 60(1):59-68. PubMed ID: 17826865
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Modalities of purine excretion during enzyme treatment of gout and other hyperuricemic conditions with urate oxidase].
    Royer R, Vindel J, Lamarche M, Kissel P.
    Presse Med (1893); 1968 Dec 14; 76(49):2325-7. PubMed ID: 5737250
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Urate-oxidase for the treatment of tophaceous gout in heart transplant recipients. A report of three cases.
    Rozenberg S, Roche B, Dorent R, Koeger AC, Borget C, Wrona N, Bourgeois P.
    Rev Rhum Engl Ed; 1995 May 14; 62(5):392-4. PubMed ID: 7655872
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [New trend in gout treatment. Clinical and biological study of urate oxidase].
    Mizon JP, Plaquet R, Gentit F, Quiret JC.
    Lille Med; 1971 Nov 14; 16(9):1332-45. PubMed ID: 4945000
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.